Journal for ImmunoTherapy of Cancer (Jun 2022)
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression
- Yuanyuan Zhang,
- Jing Huang,
- Bing Li,
- Jin Yu,
- Xiaobo Wang,
- Shiyu Shen,
- Ruina Wang,
- Hongru Tao,
- Junchi Hu,
- Hualiang Jiang,
- Kaixian Chen,
- Cheng Luo,
- Yongjun Dang
Affiliations
- Yuanyuan Zhang
- Department of Rehabilitation Medicine, Tianjin Medical University, Tianjin, China
- Jing Huang
- Aff180 grid.416466.7Department of Infectious Diseases and Hepatology UnitNanfang Hospital Guangzhou Guangdong People’s Republic of China
- Bing Li
- Guangdong Women and Children Hospital, Guangzhou, Guangdong, China
- Jin Yu
- 1 Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, Shanghai, China
- Xiaobo Wang
- 4 Department of Hepatobiliary and Pancreas Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi, China
- Shiyu Shen
- Department of Integrative Medicine and Neurobiology, State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, Shanghai Medical College of Fudan University, Shanghai, China
- Ruina Wang
- Key Laboratory of Metabolism and Molecular Medicine, The Ministry of Education, Department of Biochemistry and Molecular Biology, Fudan University School of Basic Medical Sciences, Shanghai, China
- Hongru Tao
- Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China
- Junchi Hu
- Center for Novel Target and Therapeutic Intervention, Chongqing Medical University, Chongqing, China
- Hualiang Jiang
- Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China
- Kaixian Chen
- Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China
- Cheng Luo
- Drug Discovery and Design Center, The Center for Chemical Biology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, China
- Yongjun Dang
- Key Laboratory of Metabolism and Molecular Medicine, The Ministry of Education, Department of Biochemistry and Molecular Biology, Fudan University School of Basic Medical Sciences, Shanghai, China
- DOI
- https://doi.org/10.1136/jitc-2021-003957
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.